scholarly journals Suppressed Programmed Death 1 Expression on CD4+ and CD8+ T Cells in Psoriatic Patients

2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
Joanna Bartosińska ◽  
Ewelina Zakrzewska ◽  
Dorota Raczkiewicz ◽  
Joanna Purkot ◽  
Anna Michalak-Stoma ◽  
...  

Psoriasis is a chronic inflammatory disease mediated by T cell immunity. Programmed death 1 (PD-1), a coinhibitory receptor, plays an important role in immune regulation and maintaining peripheral tolerance. The aim of the study was to compare the expression of PD-1 on the peripheral T cells between psoriatic patients and healthy controls. The study included 75 psoriatic patients and 52 healthy volunteers. The percentages and absolute numbers of CD3+, CD4+, CD8+, CD4+PD-1+, and CD8+PD-1+ T cells were analyzed using flow cytometry. The absolute numbers and percentages of CD4+PD-1+ and CD8+PD-1+ T cells were significantly decreased in the psoriatic patients in comparison with the control group. No significant correlations were found between the absolute numbers and percentages of CD4+PD-1+ or CD8+PD-1+ T cells and clinical characteristics of psoriasis. Decreased PD-1 expression on the T cells may be responsible for impaired negative regulation of immune response in psoriasis pathogenesis.

2010 ◽  
Vol 23 (10) ◽  
pp. 1393-1403 ◽  
Author(s):  
Mei-Chi Hsu ◽  
Jenn-Ren Hsiao ◽  
Kung-Chao Chang ◽  
Yuan-Hua Wu ◽  
Ih-Jen Su ◽  
...  

Inflammation ◽  
2013 ◽  
Vol 37 (1) ◽  
pp. 116-121 ◽  
Author(s):  
Shufeng Li ◽  
Wensheng Liao ◽  
Meng Chen ◽  
Shiying Shan ◽  
Yuanlin Song ◽  
...  

2010 ◽  
Author(s):  
Chantal Mengus ◽  
Clémentine Le Magnen ◽  
Cyrill Rentsch ◽  
Alexander Bachmann ◽  
Michael Heberer ◽  
...  

2020 ◽  
Vol 6 (38) ◽  
pp. eabd2712 ◽  
Author(s):  
Nikolaos Patsoukis ◽  
Qi Wang ◽  
Laura Strauss ◽  
Vassiliki A. Boussiotis

Programmed Death-1 (PD-1; CD279) is an inhibitory receptor induced in activated T cells. PD-1 engagement by its ligands, PD-L1 and PD-L2, maintains peripheral tolerance but also compromises anti-tumor immunity. Blocking antibodies against PD-1 or its ligands have revolutionized cancer immunotherapy. However, only a fraction of patients develop durable antitumor responses. Clinical outcomes have reached a plateau without substantial advances by combinatorial approaches. Thus, great interest has recently emerged to investigate, in depth, the mechanisms by which the PD-1 pathway transmits inhibitory signals with the goal to identify molecular targets for improvement of the therapeutic success. These efforts have revealed unpredictable dimensions of the pathway and uncovered novel mechanisms involved in PD-1 and PD-L1 regulation and function. Here, we provide an overview of the recent advances on the mechanistic aspects of the PD-1 pathway and discuss the implications of these new discoveries and the gaps that remain to be filled.


2011 ◽  
Vol 187 (7) ◽  
pp. 3730-3737 ◽  
Author(s):  
Gennadiy Zelinskyy ◽  
Lara Myers ◽  
Kirsten K. Dietze ◽  
Kathrin Gibbert ◽  
Michael Roggendorf ◽  
...  

2020 ◽  
Author(s):  
Mengzhou Guo ◽  
Feifei Yuan ◽  
Feng Qi ◽  
Jialei Sun ◽  
Qianwen Rao ◽  
...  

Abstract Background: fibrinogen-like protein 1 (FGL1) - Lymphocyte activating gene 3 (LAG-3) pathway is a promising immunotherapeutic target and has synergistic effect with programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1). However, the prognostic significance of FGL1-LAG-3 pathway and the correlation with PD-L1 in hepatocellular carcinoma (HCC) remain unknown.Methods: The levels of LAG-3, FGL1, PD-L1 and cytotoxic T (CD8+T) cells in 143 HCC patients were assessed by multiplex immunofluorescence. Associations between the marker’s expression and clinical significances were studied.Results: We found FGL1 and LAG-3 densities were elevated while PD-L1 and CD8 were decreased in HCC tissues compared to adjacent normal liver tissues. High levels of FGL1 were strongly associated with high densities of LAG-3+cells but not PD-L1. CD8+ T cells densities had positive correlation with PD-L1 levels and negative association with FGL1 expression. Elevated densities of LAG-3+cells and low levels of CD8+ T cells were correlated with poor disease outcome. Moreover, LAG-3+cells deteriorated patient stratification based on the abundance of CD8+ T cells. Patients with positive PD-L1 expression on tumor cells (PD-L1 TC+) tended to have an improved survival than that with negative PD-L1 expression on tumor cells (PD-L1 TC-). Furthermore, PD-L1 TC- in combination with high densities of LAG-3+cells showed the worst prognosis, and PD-L1 TC+ patients with low densities of LAG-3+cells had the best prognosis.Conclusions: LAG-3, FGL1, PD-L1 and CD8 have distinct tissue distribution and relationships with each other. High levels of LAG-3+cells and CD8+ T cells represent unfavorable and favorable prognostic biomarkers for HCC respectively.


Sign in / Sign up

Export Citation Format

Share Document